B+
Bull case
25%
Probability
Target price
$28.00
+24.9% vs current
ADNT
AdientBNYSE / Automobiles & Components
Last Price
At close
2026-06-02
AI scenario view
RankAlpha Sentiment CodexPost-earnings T+3Most likely
B
Base case
50%
Probability
Target price
$24.00
+7.0% vs current
B-
Bear case
25%
Probability
Target price
$18.00
-19.7% vs current
AI sentiment snapshot
Latest data as of 2026-05-08
Recent news sentiment (30D)
+0.2
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Sentiment proxy
+52.0
Score
AI commentary
As of May 8, 2026, the tone looks cautiously constructive rather than fully bullish. The company source on May 6, 2026 showed a profitable Q2 print and a modest FY26 guide raise, while the stock moved from the May 7, 2026 anchor close of $21.86 to about $22.78 on May 8, 2026, a roughly 4% gain that suggests a positive but not euphoric reaction. Trusted follow-up coverage framed the quarter as a beat, but reviewed sources did not surface a clear set of delayed analyst target or rating revisions by T+3, so this still reads as a monitoring setup with improved tone rather than a high-conviction re-rating call.
RankAlpha Sentiment Codex - 2026-05-08
Open post-earnings memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-06-30catalystQ2 beat-and-raise needs to hold up through delayed post-earnings digestionHigh impact
Adient confirmed Q2 FY2026 results on May 6, 2026 with net sales of $3.865B, diluted EPS of $0.34, adjusted EBITDA of $223M, and a modest FY26 guidance increase despite expected H2 input-cost pressure of about $35M; the near-term question is whether the initial positive read translates into durable estimate support rather than a one-day relief move [#8-K-2026-05-06] [#10-Q-2026-05-06] [#PR-2026-05-06].
2026-11-30eventSecond-half FY2026 margin and cash conversion will test the raised outlookHigh impact
The key follow-through event is whether Adient can convert the modest FY26 guidance raise into H2 margin and free-cash-flow delivery even as Q2 adjusted EBITDA margin slipped to 5.8% from 6.5% a year earlier and management flagged higher input costs for H2 FY2026 [#10-Q-2026-05-06] [#PR-2026-05-06].
2026-12-31catalystRomulus foam-plant integration could improve North America seating execution if savings show up in reported marginsMedium impact
Adient's April 27, 2026 Romulus foam-plant acquisition can strengthen supply control and vertical integration in seating, but the equity story likely needs visible margin or cash benefits in later reported quarters before the market rewards it materially [#PR-2026-04-27].
Recommendation
N/A
No formal recommendation provided.
As of 2026-05-08 • Updated nightlySource: Internal modelMethodology